Increasing the use of second‐line therapy is a cost‐effective approach to prevent the spread of drug‐resistant HIV: a mathematical modelling study

Introduction Earlier antiretroviral therapy (ART) initiation reduces HIV‐1 incidence. This benefit may be offset by increased transmitted drug resistance (TDR), which could limit future HIV treatment options. We analyze the epidemiological impact and cost‐effectiveness of strategies to reduce TDR. M...

Descripció completa

Dades bibliogràfiques

Autors principals:	Brooke E Nichols, Kim CE Sigaloff, Cissy Kityo, Raph L Hamers, Rob Baltussen, Silvia Bertagnolio, Michael R Jordan, Timothy B Hallett, Charles AB Boucher, Tobias F Rinke deWit, David AMC van deVijver
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2014-01-01
Col·lecció:	Journal of the International AIDS Society
Matèries:	drug resistance second‐line treatment pre‐therapy genotyping viral load monitoring cost‐effectiveness antiretroviral therapy
Accés en línia:	https://doi.org/10.7448/IAS.17.1.19164
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!